Dyrenium (Concordia Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Dyrenium drug offered from Concordia Pharmaceuticals Inc.. This Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Concordia Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | Triamterene |
| SUBSTANCE NAME: | TRIAMTERENE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1999-10-01 |
| END MARKETING DATE: | 0000-00-00 |
Dyrenium HUMAN PRESCRIPTION DRUG Details:
| Item Description | Dyrenium from Concordia Pharmaceuticals Inc. |
| LABELER NAME: | Concordia Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/1) |
| START MARKETING DATE: | 1999-10-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 59212-002_43fc7e74-83c4-484d-b151-1924f5cf1387 |
| PRODUCT NDC: | 59212-002 |
| APPLICATION NUMBER: | NDA013174 |
Other TRIAMTERENE Pharmaceutical Manufacturers / Labelers:
